A cannabis industry leader still flying under the radar
Added on 28 June 2024
- Despite the damage the Hamas attack and the state of war in Israel caused, the company managed to sustain operations and present a positive 2023 ER.
- The company is entitled to full compensation from the Israeli government for the damage taken.
- Pharmaceutical Cannabis industry is poised for significant growth in the coming years.
- InterCure stock should be considered poorly valued.
Image by wirestock on Freepik
More news
